ArticleBMC neuroscience2026
Ibogaine induces juvenile-like plasticity and modulates functional and structural regulators of plasticity in the adult mouse visual cortex.
Article in BMC neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Emerging Neurobiology of Psychedelics: Critical Periods, Metaplasticity, and Extracellular Matrix Remodeling.Annual review of neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundPsychedelics have emerged as powerful modulators of neural plasticity, yet whether the atypical psychedelic ibogaine can enhance plasticity remains poorly understood. Here, we investigated whether a single administration of ibogaine can reinstate juvenile-like experience-dependent plasticity in the adult mouse visual cortex, a canonical model for studying neuroplasticity.
resultsAdult mice were treated with ibogaine (40 mg/kg, i.p.) or vehicle, and 24 h later subjected to 4 days of monocular deprivation (MD). Behavioral visual acuity was quantified using the optomotor response test, and structural plasticity was assessed through dendritic spine density analysis following Golgi staining. Ibogaine alone did not alter visual acuity or dendritic spine density in non-deprived adults. However, when coupled with MD, ibogaine restored youthful levels of plasticity: MD significantly reduced visual acuity in the deprived eye and decreased dendritic spine density in the binocular visual cortex of ibogaine-treated, but not vehicle-treated, adult mice. To examine mechanistic correlates of these findings, we quantified perineuronal nets (PNNs), parvalbumin-positive interneurons (PVs), and inhibitory synaptic puncta labeled with the vesicular GABA transporter (vGAT). We found that ibogaine reduced PNN and PV staining intensity and density, decreased the proportion of PVs enwrapped by PNNs, and lowered vGAT-positive puncta density.
conclusionsThese results show that ibogaine re-establishes experience-dependent plasticity in the adult visual cortex and that this effect is accompanied by reductions in structural and inhibitory "brakes" on plasticity. Our findings suggest that ibogaine's long-lasting therapeutic actions can arise, at least partially, from its ability to re-open windows of heightened cortical adaptability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.